CASE STUDY · RESEARCH
Reduced trial cycle by 38% via data-driven protocol design
Client: NovaCore Labs
Life Sciences
9 months
Data Analysis, Protocol Redesign, Regulatory Advisory
The challenge
NovaCore’s discovery pipeline was slowed by fragmented data systems, redundant protocols, and manual quality checks. Time from hypothesis to first-cohort readout averaged 51 weeks.
Our approach
Astoria embedded a hybrid team of data scientists and clinical advisors. We consolidated protocol libraries, introduced adaptive trial design, and built a live decision dashboard that surfaced blockers in near-real-time.
The outcome
Cycle time compressed by 38%, quality flags dropped 60%, and the leadership team now steers R&D with weekly metric reviews instead of quarterly reports.
“Astoria’s research team rebuilt our discovery pipeline. What used to take a year now finishes in under seven months.”
— VP Discovery, NovaCore Labs
Timeline
Weeks 1-4
Discovery
Interviews across R&D, ops and QA to map the true bottleneck landscape.
Weeks 5-10
Protocol Redesign
Consolidated fragmented protocols and introduced adaptive design guardrails.
Weeks 11-24
Pilot
Two live studies executed on the new operating model with dashboard oversight.
Weeks 25-36
Scale
Rolled out organization-wide with training and a live decision cockpit.
Snapshots
